real estate | GenomeWeb

real estate

The CRISPR therapy developer is moving about a half a mile away as it launches a new division to focus on ex vivo therapies. 

The Rochester, New York-based firm is moving to Richmond, Virginia after also considering the Boston, San Francisco, and Research Triangle areas.

The 155,000-square-foot building will give the firm a home in Granta Park, a BioMed Realty Trust research center located near Cambridge University.

The firm said the office will help it strengthen ties with and provide better service to it Chinese customers.

A total of six facilities comprising more than 2 million square feet are in New York's pipeline of life-sci space, according to the panelists who spoke at the New York Biotechnology Association's annual meeting this week.

Released earlier this month, the report concluded that Arizona's life-sciences sector can expect another 11 years of steady growth if the state holds back or reverses budget cuts affecting the industry.

Researchers at Affymetrix, Genentech, and Stanford University's Genome Technology Center have created a new array-based resequencing assay that they claim is scalable enough to compete with second-generation sequencing platforms.

Top executives last week from Alexandria Real Estate Equities, BioMed Realty Trust, and HCP said life-sci shops are increasingly skittish about leasing new space for the long term, leading the REITs to reduce spending on construction and renovation projects this year.

BioRegion Newsmakers

Premium

Michael Kirschner, Vernon George, Norma Grace, Sherman McCorkle, Austin Beggs, Michael Donovan, Scott Levitan, Jinx Patel

CEO Joel Marcus offered no explanation for the delay, though he said the ongoing financial upheaval in the US has compelled the REIT to embark on a "major reduction" of capital spending.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.